We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Banned From Approving More Generic Norvasc

Law360 (March 27, 2007, 12:00 AM EDT) -- A district court has banned the federal drug agency from granting new applications by generic drug makers to market cheap copies of Pfizer’s popular Norvasc until it hears Mylan Laboratories’ case for six months’ exclusivity.

Mylan filed an emergency application for a temporary restraining order banning the U.S. Food and Drug Administration from issuing approvals to its competitors for any new ANDAs for amlodipine besylate tablets, the generic version of the blockbuster blood pressure medication, until its exclusive period expires on September 23.

The pharmaceutical company...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.